Physician profile
Dustin E Kliner
NPI 1043407802
$73,217.82
in general payments reported to CMS, 2019-2025
26 companies · $16K in 2025
The $16K reported for 2025 was more than what 92% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,119 · 2020: $223 · 2021: $6,469 · 2022: $1,944 · 2023: $17K · 2024: $25K · 2025: $16K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $18K · Travel and Lodging: $15K · Food and Beverage: $11K · Consulting Fee: $9,875 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $4,500 · Long Term Medical Supply Or Device Loan: $282 · Entertainment: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $18,425.00 |
| Travel and Lodging | $14,708.68 |
| Food and Beverage | $10,570.55 |
| Consulting Fee | $9,875.00 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $4,500.00 |
| Long Term Medical Supply Or Device Loan | $281.66 |
| Entertainment | $103.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $39,110.40 | 2021-2025 | Navitor, Portico, Amplatzer Talisman |
| Medtronic, INC. | $23,348.27 | 2021-2025 | Corevalve Evolut R, Avalus, Resolute Onyx |
| Medtronic Vascular, INC. | $5,722.45 | 2019 | |
| Boston Scientific Corporation | $1,460.74 | 2019-2025 | Watchman Access System, Avvigo Guidance System |
| Novartis Pharmaceuticals Corporation | $608.55 | 2019-2025 | |
| Shockwave Medical, INC | $604.59 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $554.05 | 2019-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Abiomed | $433.34 | 2024-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.00 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $184.29 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Janssen Pharmaceuticals, INC | $183.17 | 2019-2022 | |
| Terumo Medical Corporation | $116.01 | 2023 | Glidewire, Heartrail, Tr Band |
| Stryker Corporation | $110.68 | 2025 | Flowtriever, Artix Mt |
| Opsens INC. | $103.60 | 2023 | Optowire |
| Amgen INC. | $89.70 | 2020-2025 | Repatha |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kestra Medical Technology Services, INC. | $72.32 | 2022-2023 | Assure Wcd |
| Atricure, INC. | $61.32 | 2023-2024 | |
| E.R. Squibb & Sons, L.L.C. | $53.78 | 2024-2025 | Eliquis |
| Pfizer INC. | $45.25 | 2019-2024 | |
| Cardiovascular Systems INC. | $35.40 | 2022 | |
| Amarin Pharma, INC. | $21.52 | 2021 | |
| Irhythm Technologies, INC. | $18.99 | 2024 | Zio Xt Patch, Zio Monitor |
| Novo Nordisk INC | $17.92 | 2023 | Ozempic |
| Heartflow, INC. | $16.09 | 2023 | Ffrct |
| Astrazeneca Pharmaceuticals LP | $15.40 | 2021 | |
| Cardiva Medical, INC. | $13.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dustin Kliner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.